|
|
|
Insider
Information: |
Intrexon Corp |
Relationship: |
10% Owner |
City: |
Germantown |
State: |
MD |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
8 |
|
Direct
Shares |
139,513 |
|
Indirect Shares
|
36,745,755 |
|
|
Direct
Value |
$23,522 |
|
|
Indirect Value
|
$4,022,536 |
|
|
Total
Shares |
36,885,268 |
|
|
Total
Value |
$4,046,058 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Alaunos Therapeutics |
TCRT |
10% Owner |
2016-12-30 |
139,513 |
2016-12-30 |
9,570,094 |
Premium* |
|
Oragenics Inc |
OGEN |
10% Owner |
|
0 |
2016-06-30 |
15,481,644 |
Premium* |
|
Fibrocell Science Inc |
FCSC |
10% Owner |
|
0 |
2019-12-13 |
0 |
Premium* |
|
Theriva Biologics Ord Shs |
TOVX |
10% Owner |
|
0 |
2019-04-03 |
165,332 |
Premium* |
|
Soligenix Inc Common |
SNGX |
10% Owner |
|
0 |
2017-05-08 |
85,397 |
Premium* |
|
Armata Pharmaceuticals, Inc |
ARMP |
10% Owner |
|
0 |
2016-12-29 |
674,169 |
Premium* |
|
Ocugen Ord Shs |
OCGN |
10% Owner |
|
0 |
2019-01-15 |
1,692,366 |
Premium* |
|
Aquabounty Technologies, Inc. |
AQB |
10% Owner |
|
0 |
2018-10-25 |
9,076,753 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2015-06-04 |
4 |
D |
$0.00 |
$0 |
I/I |
(17,830,305) |
0 |
0 |
- |
|
ARMP |
Armata Pharmaceuticals, I... |
10% Owner |
|
2015-03-16 |
4 |
B |
$0.17 |
$2,300,000 |
I/I |
13,939,392 |
37,939,392 |
1.5 |
- |
|
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2015-06-04 |
4 |
A |
$0.00 |
$0 |
I/I |
8,222,953 |
86,556 |
0 |
- |
|
FCSC |
Fibrocell Science Inc |
10% Owner |
|
2013-10-01 |
4 |
B |
$4.10 |
$14,999,998 |
I/I |
3,658,536 |
5,000,325 |
1.5 |
- |
|
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2011-01-12 |
4 |
B |
$0.00 |
$0 |
I/I |
3,636,926 |
6,063,161 |
1.42 |
- |
|
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2012-11-07 |
4 |
B |
$0.00 |
$0 |
I/I |
3,636,926 |
13,533,162 |
1.42 |
- |
|
OGEN |
Oragenics Inc |
10% Owner |
|
2015-12-01 |
4 |
OE |
$1.50 |
$5,071,506 |
I/I |
3,381,004 |
12,219,670 |
0 |
- |
|
TOVX |
Theriva Biologics Ord Shs |
10% Owner |
|
2012-10-29 |
4 |
B |
$1.60 |
$5,000,000 |
I/I |
3,125,000 |
3,125,000 |
1.5 |
- |
|
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2013-10-29 |
4 |
B |
$3.50 |
$10,000,001 |
I/I |
2,857,143 |
16,390,305 |
1.5 |
- |
|
FCSC |
Fibrocell Science Inc |
10% Owner |
|
2017-12-11 |
4 |
B |
$0.77 |
$2,100,000 |
I/I |
2,727,273 |
10,806 |
1.5 |
- |
|
OGEN |
Oragenics Inc |
10% Owner |
|
2013-09-30 |
4 |
B |
$3.00 |
$7,945,530 |
I/I |
2,648,510 |
7,040,935 |
1.5 |
- |
|
TOVX |
Theriva Biologics Ord Shs |
10% Owner |
|
2013-12-17 |
4 |
B |
$1.00 |
$2,500,000 |
I/I |
2,500,000 |
8,675,768 |
1.5 |
- |
|
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2011-01-12 |
4 |
B |
$4.80 |
$11,645,928 |
I/I |
2,426,235 |
2,426,235 |
1.5 |
- |
|
AQB |
Aquabounty Technologies, ... |
10% Owner |
|
2017-01-18 |
4 |
B |
$10.33 |
$25,009,684 |
I/I |
2,421,073 |
5,161,247 |
1.5 |
- |
|
OGEN |
Oragenics Inc |
10% Owner |
|
2016-06-30 |
4 |
B |
$0.52 |
$1,166,666 |
I/I |
2,261,419 |
14,481,089 |
1.5 |
- |
|
FCSC |
Fibrocell Science Inc |
10% Owner |
|
2019-12-13 |
4 |
D |
$3.00 |
$5,838,834 |
I/I |
(1,946,278) |
0 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2012-01-20 |
4 |
B |
$5.20 |
$9,999,990 |
I/I |
1,923,075 |
9,896,236 |
1.5 |
- |
|
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2011-02-03 |
4 |
B |
$5.75 |
$10,982,500 |
I/I |
1,910,000 |
7,973,161 |
1.5 |
- |
|
AQB |
Aquabounty Technologies, ... |
10% Owner |
|
2017-01-18 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,776,557) |
2,740,174 |
0 |
- |
|
AQB |
Aquabounty Technologies, ... |
10% Owner |
|
2018-01-17 |
4 |
B |
$3.25 |
$4,999,998 |
I/I |
1,538,461 |
6,700,738 |
1.5 |
- |
|
AQB |
Aquabounty Technologies, ... |
10% Owner |
|
2018-10-25 |
4 |
OE |
$2.00 |
$3,076,922 |
I/I |
1,538,461 |
8,239,199 |
0 |
- |
|
TCRT |
Alaunos Therapeutics |
10% Owner |
|
2015-02-09 |
4 |
B |
$8.75 |
$12,600,000 |
I/I |
1,440,000 |
17,830,305 |
1.5 |
- |
|
FCSC |
Fibrocell Science Inc |
10% Owner |
|
2013-07-26 |
4 |
B |
$6.03 |
$7,499,999 |
I/I |
1,243,781 |
2,561,301 |
1.5 |
- |
|
OGEN |
Oragenics Inc |
10% Owner |
|
2013-11-20 |
4 |
B |
$2.50 |
$3,106,225 |
I/I |
1,242,490 |
8,140,425 |
1.5 |
- |
|
FCSC |
Fibrocell Science Inc |
10% Owner |
|
2014-01-24 |
4 |
B |
$4.88 |
$4,999,999 |
I/I |
1,024,590 |
6,024,915 |
1.5 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|